Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of surgical oncology"
DOI: 10.1002/jso.26650
Abstract: BACKGROUND AND OBJECTIVES The impact of perioperative blood transfusion (PBT) on outcomes for pancreatic ductal adenocarcinoma (PDAC) patients given multimodality therapy (MMT) remains undefined. We sought to evaluate the association of PBT with survival after…
read more here.
Keywords:
given multimodality;
multimodality therapy;
patients given;
therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "The Lancet"
DOI: 10.1016/s0140-6736(19)30952-3
Abstract: BACKGROUND Psoriasis is an autoimmune disease that affects approximately 100 million people worldwide, and is a disease that can be ameliorated by anti-cytokine treatment. We aimed to compare the efficacy and safety of risankizumab with…
read more here.
Keywords:
part;
risankizumab;
moderate severe;
plaque psoriasis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Evaluation in Clinical Practice"
DOI: 10.1111/jep.12854
Abstract: INTRODUCTION AND OBJECTIVE The ODHIN trial found that training and support and financial reimbursement increased the proportion of patients that were screened and given advice for their heavy drinking in primary health care. However, the…
read more here.
Keywords:
health care;
primary health;
patients given;
given advice ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-134066
Abstract: Introduction Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm which represents the most frequent hematologic malignancy in Caucasians. Every year, there are15,000 new diagnoses and 5000 CLL deaths in the United States. Its prevalence in…
read more here.
Keywords:
cll;
lymphocytic leukemia;
treatment;
patients given ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2022.280678
Abstract: Here we present the 3-year results of ZUMA-4, a phase I/II multicenter study evaluating the safety and efficacy of KTEX19, an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in pediatric/adolescent patients with relapsed/refractory B-cell…
read more here.
Keywords:
relapsed refractory;
kte x19;
lymphoblastic leukemia;
patients given ... See more keywords